Research Paper Volume 13, Issue 12 pp 16513—16526
Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer
Figure 4. Expression of deoxyribonuclease 1-like 3 (DNASE1L3) in colon cancer and its correlation with clinicopathology. (A) The expression of DNASE1L3 in colon cancer and normal samples (p<0.001, Wilcoxon rank sum test). (B) Expression analysis of DNASE1L3 in colon cancer and paired normal samples (p=2.7e-12, Wilcoxon rank sum test). (C–F) The association between DNASE1L3 and clinicopathology (Kruskal–Wallis rank sum test or Wilcoxon rank sum test, statistical significance at p<0.05).